Boosh Clarifies Beanfields Release
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or...
Day: February 14, 2022
LifeSpeak To Acquire Wellbeats – A U.S.-Based On-Demand B2B Physical Wellbeing Platform – for up to US$92.5 Million
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE...
Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO
Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn.--(BUSINESS WIRE)--Feb. 14,...
CompuMed, Inc. Announces Fiscal 2022 First Quarter Results
LOS ANGELES, CA / ACCESSWIRE / February 14, 2022 / CompuMed, Inc. (OTC PINK:CMPD) ("CompuMed" or the "Company") is pleased...
Aytu BioPharma Announces Business and Pipeline Progress and Reports Second Quarter 2022 Financial Results
Quarterly Net Revenue Increased 53% Year-over-year to $23.1 MillionPREVEnt Pivotal Study for AR101 in Vascular Ehlers-Danlos Syndrome On-track to Begin...
Lobe Sciences Ltd. Disposes Securities of Ionic Brands Corp.
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2022) - Lobe Sciences Ltd. (the "Acquiror") announces, pursuant to the early warning...
Boosh Revenues Surge Over 4,500% On Acquisition of Beanfields
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2022) - Boosh Plant-Based Brands Inc. ("Boosh" or the "Company") (CSE: VEGI) (OTCQB:...
Your Fountain of Youth Trademarked by Hemostemix
Calgary, Alberta--(Newsfile Corp. - February 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company")...
Delota Signs Share Purchase Agreement to Acquire $11.13M of Its Own Debt
Vaughan, Ontario--(Newsfile Corp. - February 14, 2022) - Delota Corp. (TSXV: LOTA) ("Delota" or the "Company"), an established Canadian cannabis...
Net Medical Provides “Gold Standard PCR” Upper Respiratory Testing, Including COVID, Flu and the Common Cold by Utilizing bioMeriux’s Biofire Tests in New Mexico. More States To Be Added.
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and...
Altamira Therapeutics Completes Final Patient Enrollment in Phase 2 ‘TRAVERS’ Clinical Trial of AM-125 for the Treatment of Acute Vertigo
75 patients randomized in Part B of study to receive either intranasal betahistine or placeboTop-line results from the trial expected...
Jesse Redden Joins Poko International as Brand Ambassador and Partner
LONDON and BELFAST, UK / ACCESSWIRE / February 14, 2022 / (CSE:POKO) - Poko Innovations Inc., an award-winning international UK...
iZafe Group Invites Shareholders and Others to a Q&A Session Following the Publishing of the Fourth Quarter Report
STOCKHOLM, SE / ACCESSWIRE / February 14, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ) - announces that in connection...
NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer
FT. MYERS, FL / ACCESSWIRE / February 14, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
Equitable Life Signs Cloud DX to Deliver New Remote Monitoring Benefits for Critical Illness Clients
Insurer is the first in Canada to offer health and medical monitoring through Cloud DX to its individual life critical...
Empower Clinics Names Carolyn Shields as SVP of Operations of Its Integrated Healthcare Clinics
Seasoned executive with more than 20 years of professional medical practice management to lead ongoing success and expansion of The...
Stereotaxis to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer...
Teclison Completes $5.9 Million Capital Raise
Led by W.T.T. Investment, the family office of Taiwan’s Tsai familyProceeds to Advance Clinical Studies of its Potential First-in-Class Therapeutic...
POINT Biopharma Provides Early-Stage Program Updates
Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for...